SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001193125-20-237429
Filing Date
2020-09-01
Accepted
2020-09-01 20:40:12
Documents
5
Effectiveness Date
2020-09-01

Document Format Files

Seq Description Document Type Size
1 S-1MEF d90908ds1mef.htm S-1MEF 35838
2 EX-5.1 d90908dex51.htm EX-5.1 7788
3 EX-23.1 d90908dex231.htm EX-23.1 1748
4 EX-23.2 d90908dex232.htm EX-23.2 1479
5 GRAPHIC g90908g0831221854786.jpg GRAPHIC 2534
  Complete submission text file 0001193125-20-237429.txt   51627
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-1MEF | Act: 33 | File No.: 333-248540 | Film No.: 201155543
SIC: 2836 Biological Products, (No Diagnostic Substances)